ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 113

$507K Total Retail Price of All Prescriptions

Rank: 30 out of 113

565 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 8,578 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 572 534 1 2
HYDROCODONE-ACETAMINOPHEN 355 291 S3 2 7
LISINOPRIL 354 330 3 3
LEVOTHYROXINE SODIUM 289 256 4 1
OMEPRAZOLE 278 238 5 5
METOPROLOL SUCCINATE 260 245 6 10
WARFARIN SODIUM 252 213 7 8
FUROSEMIDE 247 245 8 6
ATENOLOL 240 228 9 16
CITALOPRAM HBR 239 208 10 17
AMLODIPINE BESYLATE 231 226 11 4
LOSARTAN POTASSIUM 186 179 12 13
METFORMIN HCL 182 169 13 11
GLIMEPIRIDE 158 136 14 36
POTASSIUM CHLORIDE 153 151 15 12
METOPROLOL TARTRATE 150 116 16 14
PRAVASTATIN SODIUM 142 135 17 23
ATORVASTATIN CALCIUM 133 119 18 15
FLUTICASONE PROPIONATE 125 95 19 39
DOXAZOSIN MESYLATE 116 113 20 49
TAMSULOSIN HCL 113 112 21 24
ZOLPIDEM TARTRATE 113 110 21 19
SERTRALINE HCL 108 90 23 21
TRAMADOL HCL 108 81 23 29
ALLOPURINOL 102 90 25 20
CRESTOR 99 86 26 30
TRAZODONE HCL 97 83 27 41
HYDROCHLOROTHIAZIDE 96 93 28 9
CLONIDINE HCL 90 90 29 74
SPIRONOLACTONE 85 85 30 32
TRIAMTERENE-HCTZ 82 77 31 26
MELOXICAM 80 70 32 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 68 33 34
PAROXETINE HCL 73 64 34 45
CARVEDILOL 72 72 35 25
LANTUS 69 56 36 38
GABAPENTIN 68 56 37 18
BENAZEPRIL HCL 66 65 38 46
SYMBICORT 63 52 39 186
ALENDRONATE SODIUM 60 60 40 22
TERAZOSIN HCL 59 59 41 106
GEMFIBROZIL 58 50 42 61
LOVASTATIN 55 53 43 53
SYNTHROID 55 45 43 57
COMBIVENT 53 44 45 99
ADVAIR DISKUS 53 33 45 35
OXYBUTYNIN CHLORIDE 51 22 47 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.